These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34643165)

  • 1. The validity of rheumatoid arthritis diagnoses in Finnish biobanks.
    Paltta J; Heikkilä HK; Pirilä L; Eklund KK; Huhtakangas J; Isomäki P; Kaipiainen-Seppänen O; Kristiansson K; Havulinna AS; Sokka-Isler T; Palomäki A;
    Scand J Rheumatol; 2023 Jan; 52(1):1-9. PubMed ID: 34643165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available.
    Curtis JR; Xie F; Zhou H; Salchert D; Yun H
    Arthritis Res Ther; 2020 Oct; 22(1):242. PubMed ID: 33059732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia.
    Almutairi K; Inderjeeth C; Preen DB; Keen H; Rogers K; Nossent J
    Rheumatol Int; 2021 Apr; 41(4):741-750. PubMed ID: 33620516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive predictive value of first-time rheumatoid arthritis diagnoses and their serological subtypes in the Danish National Patient Registry.
    Linauskas A; Overvad K; Johansen MB; Stengaard-Pedersen K; de Thurah A
    Clin Epidemiol; 2018; 10():1709-1720. PubMed ID: 30538575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study.
    Ng B; Aslam F; Petersen NJ; Yu HJ; Suarez-Almazor ME
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1490-6. PubMed ID: 22623324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.
    Chung CP; Rohan P; Krishnaswami S; McPheeters ML
    Vaccine; 2013 Dec; 31 Suppl 10():K41-61. PubMed ID: 24331074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000-2007.
    Rantalaiho V; Kautiainen H; Virta L; Korpela M; Möttönen T; Puolakka K
    Scand J Rheumatol; 2011 Jan; 40(1):16-21. PubMed ID: 20726683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population.
    Äyräväinen L; Leirisalo-Repo M; Kuuliala A; Ahola K; Koivuniemi R; Meurman JH; Heikkinen AM
    BMJ Open; 2017 Jan; 7(1):e011916. PubMed ID: 28143836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of rheumatoid arthritis diagnoses in health care utilization data.
    Kim SY; Servi A; Polinski JM; Mogun H; Weinblatt ME; Katz JN; Solomon DH
    Arthritis Res Ther; 2011 Feb; 13(1):R32. PubMed ID: 21345216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of autoantibody testing for validating self-reported diagnoses of rheumatoid arthritis in the Women's Health Initiative.
    Walitt B; Mackey R; Kuller L; Deane KD; Robinson W; Holers VM; Chang YF; Moreland L
    Am J Epidemiol; 2013 May; 177(9):887-93. PubMed ID: 23492764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY; Yang CT; Cheng CH; Yu KH
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of self-reported rheumatoid arthritis in a large cohort: results from the Black Women's Health Study.
    Formica MK; McAlindon TE; Lash TL; Demissie S; Rosenberg L
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):235-41. PubMed ID: 20191523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACPA Antibodies Titer at the Time of Rheumatoid Arthritis Diagnosis Is Not Associated with Disease Severity.
    Shpatz R; Braun-Moscovici Y; Balbir-Gurman A
    Isr Med Assoc J; 2021 Oct; 23(10):646-650. PubMed ID: 34672447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
    Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
    Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000-8.
    Rantalaiho VM; Kautiainen H; Järvenpää S; Virta L; Pohjolainen T; Korpela M; Möttönen T; Puolakka K
    Ann Rheum Dis; 2013 May; 72(5):672-7. PubMed ID: 22679306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis.
    Rannio T; Asikainen J; Kokko A; Hannonen P; Sokka T
    J Rheumatol; 2016 Apr; 43(4):699-706. PubMed ID: 26879355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis.
    Molander V; Bower H; Askling J
    Scand J Rheumatol; 2023 Mar; 52(2):111-117. PubMed ID: 35023437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The validity of systemic sclerosis diagnoses in two university hospitals in Finland.
    Paltta J; Kortelainen S; Käyrä M; Pirilä L; Huhtakangas J; Palomäki A
    Scand J Rheumatol; 2023 Jan; 52(1):84-87. PubMed ID: 35442148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort.
    Mouterde G; Rincheval N; Lukas C; Daien C; Saraux A; Dieudé P; Morel J; Combe B
    Arthritis Res Ther; 2019 Jun; 21(1):140. PubMed ID: 31171038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.